The Worldwide Influenza Market

Published by: BCC Research

Published: May. 30, 2006 - 139 Pages

Table of Contents

INTRODUCTION

STUDY GOALS AND OBJECTIVES

REASONS FOR DOING THE STUDY

SCOPE AND FORMAT

METHODOLOGY

RELATED BCC STUDIES

ANALYST CREDENTIALS

BCC ONLINE SERVICES

DISCLAIMER

SUMMARY

THE INFLUENZA MARKET: MAJOR MARKETS

SUMMARY TABLE GLOBAL FORECAST OF THE INFLUENZA MARKET BY PRODUCT SEGMENT, THROUGH 2010 ($ MILLION)

SUMMARY FIGURE WORLDWIDE INFLUENZA MARKET ANALYSIS BY PRODUCT SEGMENT, 2003-2010 ($ MILLIONS)

INDUSTRY OVERVIEW

TABLE 1 VACCINE RECOMMENDATIONS

HISTORY OF THE MARKET

EPIDEMICS/PANDEMICS

Spanish Influenza 1918-1919

Hong Kong Influenza 1968

Russian Influenza 1977

Asian Influenza 1957

Swine Flu 1976

Avian Flu 1961, 1997, 2003-Present

Virus Mutations

Types of Influenza

Influenza Type A

Influenza A H5

Influenza A H7

Influenza A H9

Influenza Type B

Influenza Type C

TABLE 2 WORLDWIDE INFLUENZA ACTIVITY

VIRAL SURVEILLANCE

TABLE 3 VIRAL SURVEILLANCE, PERCENTAGE OF INFLUENZA VIRUS TYPE, 2004-2005 AND 2005-2006 FLU SEASONS (%)

CURRENT H5N1 VIRUS “DRIFT AND SHIFT”

DEVELOPMENT OF FLU VACCINES

TABLE 4 INFLUENZA RESEARCH TEAMS AND AREAS OF STUDY

WORLD DEMOGRAPHICS AND INCIDENCE/MORTALITY

TABLE 5 ESTIMATED GLOBAL POPULATION BY SELECTED AGE GROUP, 2003-2010 (MILLIONS)

FIGURE 1 ESTIMATED WORLD POPULATION BY SELECTED AGE GROUP, 2003-2010 (MILLIONS)

TABLE 6 ESTIMATED WORLD POPULATION INCLUDING SOME COUNTRIES, 2003-2010 (MILLIONS)

FIGURE 2 ESTIMATED WORLD POPULATION BY REGION, 2003- 2010 (MILLIONS)

TABLE 7 WORLDWIDE VIRAL STATISTICS, 2005

TABLE 8 UNITED STATES VIRAL STATISTICS, 2005

ISSUES AFFECTING THE MARKET

GOVERNMENT INTERVENTION

UNITED STATES

TABLE 9 COUNTRIES WITH US EMBARGOES FOR BIRDS

Chinese and United States Governments

Turkey and the United States

WHO and CDC

WHO

TABLE 10 WHO REPORTED CASES OF AVIAN FLU IN HUMANS, MARCH 2006

The WHO and Containment Issues

TABLE 11 APPROVED WHO INFLUENZA CENTERS BY REGION

CDC

TABLE 12 CONFIRMED CASES OF AVIAN FLU OUTBREAKS IN ANIMALS WORLDWIDE, 2003 TO PRESENT

LEGISLATION

Department of Defense, Emergency Supplemental Appropriations to Address Hurricanes in The Gulf OF Mexico

Global Network for Avian Influenza Surveillance Act

Pandemic Preparedness and Response Act

Pandemic and Seasonal Influenza Act Of 2005

Seasonal Influenza and Pandemic Preparation Act of 2005

National Biodefense and Pandemic Preparedness Act of 2005

EPIDEMIC/PANDEMIC PREPAREDNESS

TABLE 13 ALLOCATED FUNDS FOR INFLUENZA RESEARCH AND DEVELOPMENT

IMMATERIALIZED MARKET RISK

VACCINE STOCKPILES

MEDIA COVERAGE AND VACCINATIONS

EPIDEMIC/PANDEMIC THREAT

TABLE 14 ESTIMATED INCIDENCE OF INFLUENZA IN SEVERE OUTBREAKS BASED ON POPULATION ESTIMATES, US CENSUS BUREAU INTERNATIONAL DATABASE

TABLE 15 PREDICTED IMPACT ON HEALTH SERVICES FROM THE

NEXT INFLUENZA PANDEMIC IN THE TROPICS, BASED ON CDC’S FLUAID PREDICTION MODEL FOR PEAK WEEK

TECHNOLOGY

CURRENT USES OF TECHNOLOGY

CDC TESTING KIT

BD MEDICAL AND GLA

PATENT ANALYSIS

TABLE 16 US PATENT EVALUATION FOR MAJOR TECHNOLOGY

BY ISSUE DATE

TABLE 17 US PATENT EVALUATION FOR MAJOR INFLUENZA MARKET COMPETITORS, BY PATENT HOLDER AND NUMBER OF PATENTS

FIGURE 3 US PATENT EVALUATION FOR MAJOR INFLUENZA TECHNOLOGY PATENT HOLDERS, BY PERCENT (%)

EMERGING AREAS OF TECHNOLOGY

Stmicroelectronics and Veredus Laboratories

Sanofi Pasteur and BD Biosciences

NASAL POWDER VACCINE

INFLUENZA THERAPIES/VACCINES

OVERVIEW

PRODUCT DESCRIPTIONS

TABLE 18 MARKETED FLU VIRUS PRODUCTS, THROUGH 2005

TABLE 19 GENERIC AVAILABILITY

TABLE 20 VACCINE AVERAGE PRICE PER UNIT DOSE, 2005-

INFLUENZA SEASON

RESEARCH AND DEVELOPMENT

TABLE 21 RESEARCH AND DEVELOPMENT EFFORTS BY STATUS

MARKET ANALYSIS

TABLE 22 GLOBAL FORECAST FOR INFLUENZA THERAPEUTIC AND VACCINE REVENUES BY MARKET, THROUGH 2010 ($ MILLIONS)

FIGURE 4 GLOBAL FORECAST FOR INFLUENZA THERAPEUTICS AND VACCINES BY REGION, 2003-2010 ($ MILLIONS)

TABLE 23 GLOBAL FORECAST FOR INFLUENZA THERAPEUTICS AND VACCINES BY PRODUCT TYPE, THROUGH 2010 ($ MILLIONSA

FIGURE 5 REVENUES FOR INFLUENZA THERAPEUTICS AND VACCINES BY PRODUCT TYPE, 2003-2010 ($ MILLIONS)

TABLE 24 UNITS FOR INFLUENZA THERAPEUTICS AND VACCINES BY PRODUCT, 2005-2006 SEASON (MILLION UNITS)

FIGURE 6 SHARE OF UNITS FOR INFLUENZA THERAPEUTICS AND VACCINES BY PRODUCT, 2005-2006 SEASON (%)

LEADING SUPPLIERS AND PARTICIPANTS

TABLE 25 LEADING PARTICIPANTS FOR INFLUENZA THERAPEUTICS/VACCINES BY PERCENT, 2005 (%)

FIGURE 7 LEADING PARTICIPANTS FOR INFLUENZA THERAPEUTICS/VACCINES BY PERCENT, 2005 (%)

INFLUENZA DIAGNOSTICS

OVERVIEW

TABLE 26 INFLUENZA DIAGNOSTIC TABLE

PRODUCT DESCRIPTIONS

CONVENTIONAL LABORATORY TESTS

RAPID TESTING

TABLE 27 MARKETED PRODUCTS, THROUGH 2005

TABLE 28 RAPID INFLUENZA TESTS AVERAGE PRICE

LABORATORY TEST SERVICES

TABLE 29 PROVIDERS OF LABORATORY TEST SERVICES

MARKET ANALYSIS

TABLE 30 REVENUES FOR INFLUENZA DIAGNOSTICS BY MARKET, THROUGH 2010 ($ MILLIONS)

FIGURE 8 REVENUES FOR INFLUENZA DIAGNOSTICS BY MARKET, 2003-2010 ($ MILLIONS)

TABLE 31 REVENUES FOR INFLUENZA DIAGNOSTICS BY PRODUCT TYPE, THROUGH 2010 ($ MILLIONS)

FIGURE 9 REVENUES FOR INFLUENZA DIAGNOSTICS BY PRODUCT TYPE, 2003-2010 ($ MILLIONS)

TABLE 32 GLOBAL FORECAST OF INFLUENZA DIAGNOSTICS SERVICE REVENUES, THROUGH 2010 ($ MILLIONS)

FIGURE 10 REVENUES FOR INFLUENZA DIAGNOSTICS SERVICES, 2003-2010 ($ MILLIONS)

TABLE 33 GLOBAL FORECAST OF INFLUENZA DIAGNOSTIC PRODUCT AND SERVICES MARKET REVENUES, THROUGH ($ MILLION)

FIGURE 11 GLOBAL INFLUENZA DIAGNOSTIC PRODUCT AND SERVICES MARKET REVENUES, 2003-2010 ($ MILLION)

LEADING SUPPLIERS AND PARTICIPANTS

TABLE 34 LEADING PARTICIPANTS FOR INFLUENZA DIAGNOSTICS BY PERCENT, 2005 (%)

FIGURE 12 LEADING PARTICIPANTS FOR INFLUENZA DIAGNOSTICS BY PERCENT, 2005 (%)

MARKET SUMMARY

TOTAL MARKET ANALYSIS

TABLE 35 GLOBAL FORECAST OF THE INFLUENZA MARKET BY PRODUCT SEGMENT, THROUGH 2010 ($ MILLION)

FIGURE 13 GLOBAL FORECAST OF THE INFLUENZA MARKET BY PRODUCT SEGMENT, 2003-2010 ($ MILLION)

INDUSTRY PARTICIPANTS

TABLE 36 MAJOR INDUSTRY PARTICIPANTS BY PRODUCT SEGMENT

COMPANY PROFILES

ACAMBIS

ALPHAVA

ALNYLAM PHARMACEUTICALS

APPLIED BIOSYSTEMS

AVI BIOPHARMA

BECTON-DICKINSON

BIOCRYST PHARMACEUTICALS, INC

BIOTA HOLDINGS LTD

CHIRON CORP

ENDO PHARMACEUTICALS HOLDINGS INC

FOREST LABORATORIES, INC

GLA

HEMISPHER

INVERNESS MEDICAL-BIOSTAR, INC

MEDIMMUNE VACCINES, INC

OTSUKA PHARMACEUTICAL CO, LTD

PATHOLOGY ASSOCIATES MEDICAL LABORATORIES (PAML)

QUEST DIAGNOSTICS

QUIDEL CORP

REMEL, INC

ROCHE HOLDINGS LTD

SANOFI PASTEUR

SOLVAY PHARMACEUTICALS, INC

SYSME

TEVA PHARMACEUTICALS INDUSTRIES LTD

VIROMED LABORATORIES, INC

ZYMET

APPENDIX

FIGURE 14 COMPANIES MENTIONED IN THE MARKET FOR

INFLUENZA TREATMENTS AND DIAGNOSTICS, BY TYPE (NUMBER OF COMPANIES)

LEADING PRODUCT PROVIDERS

RESEARCH AND DEVELOPMENT AND AFFILIATED COMPANIES

MENTIONED UNIVERSITIES

Abstract

• By 2010, the worldwide influenza market is likely to reach $7.1 billion, with average annual growth estimated at 19.8%.
• The worldwide influenza market is estimated at $2.9 billion in 2005, up from $1.5 billion the previous year.
• The market is estimated to reach $7.1 billion in 2010, an increase of more than $4.2 billion over the forecast period.
• The worldwide therapeutics/vaccines market is likely to reach $6.9 billion in 2010, with average annual growth estimated at 20.8%.

• Provides a thorough evaluation of the market for influenza vaccines, therapeutics, and diagnostics.
• Offers a global analysis, with emphasis on U.S. data, and a five-year forecast period through 2010.
• Identifies markets in general segments: Vaccines/Therapeutics and Diagnostics. Each market segment discussion provides detailed information based on product categories, use of products, forecasts, and competitive analysis.
• Covers some of the most significant issues, trends and market factors.
• Profiles the top companies and major players in the market.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 300,000 market research reports, company profiles and country profiles from over 700 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.